"Designing Growth Strategies is in our DNA"

Tardive Dyskinesia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug (Deutetrabenazine, Valbenazine, and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2023-2030

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI107532

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Tardive Dyskinesia, By Key Countries, 2022
    2. Key Industry Developments
    3. Pipeline Analysis
    4. Economic Cost Burden for the Treatment of Tardive Dyskinesia
    5. Regulatory & Reimbursement Scenario, By Key Regions
    6. Impact of COVID-19 on the Market
  5. Global Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Region
      1. U.S.
      2. Europe
      3. Asia Pacific
      4. Rest of the World
  6. U.S. Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. Europe Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. Germany
      2. U.K.
      3. France
      4. Italy
      5. Spain
      6. Rest of Europe
  8. Asia Pacific Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    3. Market Analysis, Insights and Forecast – By Country/Sub-Region
      1. China
      2. Japan
      3. India
      4. Australia
      5. Rest of Asia Pacific
  9. Rest of the World Tardive Dyskinesia Therapeutics Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug
      1. Deutetrabenazine
      2. Valbenazine
      3. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2022)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Neurocrine Biosciences, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Mitsubishi Chemical Group Corporation.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. SOM BIOTECH
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Luye Pharma Group
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Drug, 2022 & 2030

Figure 2:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Distribution Channel, 2022 & 2030

Figure 3:  Global Tardive Dyskinesia Therapeutics Market Value Share (%), By Country/Region, 2022 & 2030

Figure 4:  U.S. Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2022 & 2030

Figure 5:  U.S. Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2022

Figure 6:  U.S. Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 7:  U.S. Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 8:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2022 & 2030

Figure 9:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2022

Figure 10:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 11:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 12:  Europe Tardive Dyskinesia Therapeutics Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 13:  Europe Tardive Dyskinesia Therapeutics Market Value Share (%), by Country/ Sub-Region, 2022

Figure 14:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2022 & 2030

Figure 15:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2022

Figure 16:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 17:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2022

Figure 18:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value (USD billion), by Country/ Sub-Region, 2022 & 2030

Figure 19:  Asia Pacific Tardive Dyskinesia Therapeutics Market Value Share (%), by Country/ Sub-Region, 2022

Figure 20:  Rest of the World Tardive Dyskinesia Therapeutics Market Value (USD billion), by Drug, 2022 & 2030

Figure 21:  Rest of the World Tardive Dyskinesia Therapeutics Market Value Share (%), by Drug, 2022

Figure 22:  Rest of the World Tardive Dyskinesia Therapeutics Market Value (USD billion), by Distribution Channel, 2022 & 2030

Figure 23:  Rest of the World Tardive Dyskinesia Therapeutics Market Value Share (%), by Distribution Channel, 2022

Table 1:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2019-2030

Table 2:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 3:  Global Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/Region, 2019-2030

Table 4:  U.S. Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2019-2030

Table 5:  U.S. Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 6:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2019-2030

Table 7:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 8:  Europe Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

Table 9:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2019-2030

Table 10:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Table 11:  Asia Pacific Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Country/ Sub-Region, 2019-2030

Table 12:  Rest of the World Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Drug, 2019-2030

Table 13:  Rest of the World Tardive Dyskinesia Therapeutics Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2030

Tardive Dyskinesia Therapeutics Market Size, Share and Global Industry Trend Forecast till 2030
  • 2019-2030
  • 2022
  • 2019-2021
  • 101
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase